Document is current

Any future updates will be listed below

Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay

Crossref DOI link: https://doi.org/10.1007/s13365-016-0482-z

Published Online: 2016-10-11

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark